Publications by authors named "Cheng-Ping Yu"

Claim this Profile
E
Extracellular Vesicle-Mediated Regulation of H3C14 Contributes to Gemcitabine Resistance in Bladder Cancer.
Cheng-Shuo Huang, Dah-Shyong Yu, Shih Sheng Jiang, Ying-Si Wu, Jar-Yi Ho, Cheng-Ping Yu

J Extracell Vesicles· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Non-Benzodiazepine Hypnotics and Tinnitus: A Nationwide Cohort Study in Taiwan.
Jen-Tin Lee, Hui-Wen Yang, Cheng-Ping Yu, Yuan-Liang Wen, Sheng-Yin To

Nat Sci Sleep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NUFIP1 integrates amino acid sensing and DNA damage response to maintain the intestinal homeostasis.
Hui Ming, Jing Tan, Si-Yi Cao, Cheng-Ping Yu, Yu-Ting Qi, Jian Yuan

Nat Metab· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of extracellular vesicles loaded with immune checkpoint inhibitors for immunotherapeutic management of glioma.
Shang-Wen Lin, Cheng-Ping Yu, Jui-Chen Tsai, Yan-Jye Shyong

Mater Today Bio· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Advanced Machine Learning Model for a Web-Based Artificial Intelligence-Based Clinical Decision Support System Application: Model Development and Validation Study.
Tai-Han Lin, Hsing-Yi Chung, Ming-Jr Jian, Chih-Kai Chang, Cherng-Lih Perng, Jyh-Cherng Yu, Cheng-Ping Yu

J Med Internet Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of oral chemotherapeutic reversal agents for treating multidrug resistance cancer.
Ko-Hua Yu, I-Ting Wu, Cheng-Ping Yu, Wei-Chun Wang, Ching-Ho Chi

Eur J Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long acting tariquidar loaded stearic acid-modified hydroxyapatite enhances brain penetration and antitumor effect of temozolomide.
Cheng-Ping Yu, Shang-Wen Lin, Jui-Chen Tsai, Yan-Jye Shyong

Eur J Pharm Biopharm· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A glucose-blue light AND gate-controlled chemi-optogenetic cell-implanted therapy for treating type-1 diabetes in mice.
Chi-Yu Li, Ting Wu, Xing-Jun Zhao, Cheng-Ping Yu, Zi-Xue Wang

Front Bioeng Biotechnol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza A virus NS1 protein represses antiviral immune response by hijacking NF-κB to mediate transcription of type III IFN.
Meng-Chang Lee, Cheng-Ping Yu, Xing-Hong Chen, Ming-Tsan Liu, Ji-Rong Yang, An-Yu Chen

Front Cell Infect Microbiol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast cross-staining alignment of gigapixel whole slide images with application to prostate cancer and breast cancer analysis.
Ching-Wei Wang, Yu-Ching Lee, Muhammad-Adil Khalil, Kuan-Yu Lin, Cheng-Ping Yu

Sci Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Oncocytic Adrenal Cortical Neoplasm with Uncertain Malignant Potential Turned Out to Be Oncocytic Adrenal Cortical Carcinoma with Distant Metastasis: Could Pathology Do Better Initially?
Chien-Peng Huang, Ming-Shen Dai, Chien-Chang Kao, Wen-Chiuan Tsai, Cheng-Ping Yu

Medicina (Kaunas)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer.
Cheng-Shuo Huang, Chen-Hua Tsai, Cheng-Ping Yu, Ying-Si Wu, Ming-Fong Yee, Dah-Shyong Yu

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters.
Ying-Si Wu, Jar-Yi Ho, Cheng-Ping Yu, Chun-Jung Cho, Chia-Lun Wu, Dah-Shyong Yu

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased drug resistance of bladder cancer using phytochemicals treatment.
Chun-Jung Cho, Cheng-Ping Yu, Chia-Lun Wu, Jar-Yi Ho, Ching-Wei Yang, Dah-Shyong Yu

Kaohsiung J Med Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Had a Better Outcome Than Those with Lower Levels of Tumor Progesterone Receptor.
Tai-Han Lin, Hong-Wei Gao, Guo-Shiou Liao, Jyh-Cherng Yu, Ming-Shen Dai, Cheng-Ping Yu

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells.
Cheng-Shuo Huang, Jar-Yi Ho, Jung-Hwa Chiang, Cheng-Ping Yu, Dah-Shyong Yu

Cells· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol.
Chun-Jung Cho, Ching-Wei Yang, Chia-Lun Wu, Jar-Yi Ho, Cheng-Ping Yu, Dah-Shyong Yu

Oncol Lett· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases.
Jui-Ming Liu, Cheng-Ping Yu, Heng-Chang Chuang, Chun-Te Wu, Ren-Jun Hsu

Prostate Cancer Prostatic Dis· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Overdiagnosis on Long-Term Breast Cancer Survival.
Jean Ching-Yuan Fann, King-Jen Chang, Chen-Yang Hsu, Amy Ming-Fang Yen, Cheng-Ping Yu

Cancers (Basel)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidating the Reaction Pathway of Decarboxylation-Assisted Olefination Catalyzed by a Mononuclear Non-Heme Iron Enzyme.
Cheng-Ping Yu, Yijie Tang, Lide Cha, Sergey Milikisiyants, Tatyana I Smirnova

J Am Chem Soc· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Risk of Ulcerative Colitis in Patients with Periodontal Disease: A Nationwide Population-Based Cohort Study.
Chien-Yu Lin, Kuo-Sen Tseng, Jui-Ming Liu, Heng-Chang Chuang, Chi-Hone Lien, Cheng-Ping Yu

Int J Environ Res Public Health· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic Investigation of Oxidative Decarboxylation Catalyzed by Two Iron(II)- and 2-Oxoglutarate-Dependent Enzymes.
Jhih-Liang Huang, Yijie Tang, Cheng-Ping Yu, Dev Sanyal, Xinglin Jia, Xinyu Liu

Biochemistry· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of p-FOXO3/FOXO3 in bladder cancer and its correlation with clinicopathology and tumor recurrence.
Dah-Shyong Yu, Yi-Ting Chen, Chia-Lun Wu, Cheng-Ping Yu

Int J Clin Exp Pathol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.
Jar-Yi Ho, Ren-Jun Hsu, Jui-Ming Liu, Szu-Chi Chen, Guo-Shiou Liao, Cheng-Ping Yu

Oncotarget· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2.
Jar-Yi Ho, Ren-Jun Hsu, Chih-Hsi Wu, Guo-Shiou Liao, Hong-Wei Gao, Cheng-Ping Yu

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis